Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Vigabatrin: balancing effectiveness vs. (irreversible) visual field loss as a side effect].

P Hardus1, M Engelsman, C W van Veelen

  • 1Academisch Ziekenhuis, afd. Oogheelkunde, Groningen. p.l.l.j.hardus@ohk.azg.nl

Nederlands Tijdschrift Voor Geneeskunde
|November 10, 2000
PubMed
Summary

Vigabatrin, an antiepileptic drug, can cause irreversible visual field loss in 30-40% of patients. This condition affects the inner retina and is linked to cumulative dosage, necessitating careful patient monitoring.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The rationale for intensity-modulated proton therapy in geometrically challenging cases.

Physics in medicine and biology·2013
Same author

Infectious uveitis: recent advances in diagnosis and treatment.

Nepalese journal of ophthalmology : a biannual peer-reviewed academic journal of the Nepal Ophthalmic Society : NEPJOPH·2012
Same author

Prevention of ocular firework injuries.

Nepalese journal of ophthalmology : a biannual peer-reviewed academic journal of the Nepal Ophthalmic Society : NEPJOPH·2012
Same author

Direct absorbed dose to water determination based on water calorimetry in scanning proton beam delivery.

Medical physics·2010
Same author

Long-term ocular complications in aphakic versus pseudophakic eyes of children with juvenile idiopathic arthritis-associated uveitis.

The British journal of ophthalmology·2010
Same author

Ocular firework trauma: a systematic review on incidence, severity, outcome and prevention.

The British journal of ophthalmology·2009

Area of Science:

  • Ophthalmology
  • Neuroscience
  • Pharmacology

Background:

  • Vigabatrin is an antiepileptic medication.
  • A significant percentage of patients experience visual field contraction with vigabatrin use.
  • This visual field loss is progressive and irreversible.

Purpose of the Study:

  • To investigate the characteristics of vigabatrin-induced visual field loss.
  • To identify the retinal location and potential mechanisms of this adverse effect.
  • To emphasize the importance of visual field examination in managing vigabatrin therapy.

Main Methods:

  • Review of clinical data and patient outcomes.
  • Correlation analysis between cumulative vigabatrin dose and visual field defects.
  • Electrophysiological and color vision assessments.

Related Experiment Videos

Main Results:

  • Asymptotic concentric visual field contraction observed in 30-40% of patients.
  • Visual field loss correlated with cumulative vigabatrin dose.
  • Pathology localized to the inner retina (horizontal/amacrine cells).

Conclusions:

  • Vigabatrin-induced visual field loss is a serious, irreversible side effect.
  • Inner retinal cells are the primary site of damage.
  • Regular visual field testing is crucial for early detection and management decisions.